Wu, T., Xu, Y., Gong, K., Zhuang, L., Tang, H., Zou, Y., Deng, W., Du, W., Zhou, P., Chen, Z., Xiao, R., Liao, L., Liu, C. (2025). Neoadjuvant cadonilimab (anti-PD-1/CTLA-4 bispecific antibody) plus chemotherapy in early or locally advanced triple-negative breast cancer: A single-arm phase II trial (CABIN study).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.599